Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
14
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Apollomics Inc - Ordinary Shares - Class A market cap is $45.28M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Apollomics Inc - Ordinary Shares - Class A 52 week high is $28.29 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Apollomics Inc - Ordinary Shares - Class A 52 week low is $12.58 as of November 22, 2026.
Apollomics Inc - Ordinary Shares - Class A stock price today is $15.54.
Apollomics Inc - Ordinary Shares - Class A stock price yesterday was $16.69.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Apollomics Inc - Ordinary Shares - Class A's P/E ratio is -59.57.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Apollomics Inc - Ordinary Shares - Class A P/B ratio is 3.5222.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Apollomics Inc - Ordinary Shares - Class A 50-day moving average is $20.99.
Apollomics Inc - Ordinary Shares - Class A has 14 employees.